Recombinant Bacillus subtilis Holin-like protein CidA (cidA) is a bacterially expressed protein engineered to study its structural and functional roles in bacterial physiology. Produced in Escherichia coli with an N-terminal His tag, this 128-amino-acid full-length protein (UniProt ID: P39591) shares homology with holins—membrane proteins that regulate cell lysis and death .
CidA functions as a holin-like protein, modulating murein hydrolase activity and cell lysis in a manner analogous to bacteriophage holins . Key findings include:
Murein Hydrolase Activation: CidA enhances extracellular murein hydrolase activity, promoting peptidoglycan degradation and penicillin sensitivity .
Antiholin Interaction: CidA operates antagonistically with LrgA (antiholin-like protein), forming a regulatory system for controlled cell lysis during biofilm development .
Biofilm Dynamics: CidA-mediated lysis facilitates extracellular DNA release, a critical component of biofilm matrices .
E. coli Lysis Assays: Heterologous expression of CidA in E. coli supports bacteriophage endolysin-induced lysis, confirming pore-forming capability .
Liposome Leakage: Purified CidA induces carboxyfluorescein leakage in liposomes, demonstrating direct membrane disruption .
Cell Death Studies: Investigates programmed cell death mechanisms in Bacillus and Staphylococcus species .
Biofilm Research: Explores CidA’s role in biofilm maturation and structural integrity .
Antibiotic Sensitivity: Evaluates how CidA overexpression alters bacterial responses to β-lactam antibiotics .
Biotechnological Tool: Utilized for controlled bacterial lysis in protein purification or metabolite release .
Antibiotic Adjuvant Development: Targeting CidA-LrgA interactions could enhance antibiotic efficacy against persistent infections .
Recombinant CidA is typically purified via immobilized metal affinity chromatography (IMAC) due to its His tag . Critical considerations include:
Reconstitution: Dissolve lyophilized protein in deionized water (0.1–1.0 mg/mL) with 5–50% glycerol for stability .
Storage: Aliquot at -20°C/-80°C to prevent freeze-thaw degradation .
While CidA’s holin-like activity is well-established, its endogenous regulation in B. subtilis remains less characterized compared to S. aureus homologs . Future studies may explore:
KEGG: bsu:BSU38320
STRING: 224308.Bsubs1_010100020686
Bacillus subtilis Holin-like protein CidA (cidA) is a 128-amino acid protein that functions as a murein hydrolase regulator. The protein has several identified synonyms in research literature including ywbH, BSU38320, and ipa-23r . The full amino acid sequence is: MKKLLLTVIQIALLFIFARLINWVTALLHINIPGSIIGIVILFTLLHFNIIKLEWIELGAAWLLGELLLFFIPSAVGVIEYGDIMSKFGVSILLVVIISTFVVMVSTGTLTQLIAKRKEKKHTCSSEL .
Based on structural analysis, CidA proteins are considered holin-like proteins that may form pores in the cytoplasmic membrane, contributing to the regulation of cell wall degradation and autolysis processes. The protein has a UniProt ID of P39591 and is often studied in the context of bacterial programmed cell death mechanisms .
While both Bacillus subtilis and Staphylococcus aureus possess cidA genes that encode holin-like proteins, their functions show both similarities and species-specific differences:
In S. aureus, cidA-controlled cell lysis plays a significant role during biofilm development, and the released genomic DNA serves as an important structural component of the biofilm matrix . Similar functions may exist in B. subtilis, though direct experimental evidence comparing the two species' cidA functions would require further investigation.
The cidA gene is proposed to encode components of a bacterial programmed cell death and lysis mechanism . For researchers studying this process, the following methodological approaches are recommended:
Genetic manipulation approaches: Generate cidA knockout mutants using allelic replacement or CRISPR-Cas9 techniques. Compare these mutants with wild-type strains under various stress conditions to evaluate differences in cell lysis patterns.
Cell death assessment methods: Use dual fluorescent staining (e.g., SYTO 9/propidium iodide) to distinguish between live and dead cells within bacterial populations. Flow cytometry can provide quantitative data on population heterogeneity.
Molecular detection of lysis: Measure the release of intracellular markers like β-galactosidase into culture supernatants as an indicator of cell lysis, as demonstrated in studies with S. aureus cidA mutants .
Membrane potential analysis: Since holin-like proteins typically affect membrane integrity, membrane potential measurements using voltage-sensitive dyes can help characterize cidA's effects.
It's important to note that while cidA's role in programmed cell death has been proposed, the complete biological significance and regulatory mechanisms remain areas of active investigation requiring multifaceted experimental approaches.
Researchers have several options for recombinant cidA expression, each with distinct advantages and limitations:
For the E. coli expression system documented in the search results, the recombinant protein includes the full-length cidA (1-128aa) with an N-terminal His tag . After expression, the protein is purified to greater than 90% as determined by SDS-PAGE . Researchers should consider that membrane proteins like cidA may require careful optimization of induction conditions, temperature, and extraction methods to maximize functional yield.
Based on experimental data, the following protocol is recommended for optimal storage and reconstitution of recombinant cidA:
Storage conditions:
Reconstitution protocol:
Briefly centrifuge the vial prior to opening to bring contents to the bottom
Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration of 5-50% (recommended default is 50%) for long-term storage
For storage buffer, a Tris/PBS-based buffer with 6% Trehalose at pH 8.0 has been effectively used
Designing functional assays for cidA presents several technical challenges due to its membrane-associated nature and role in cell death processes:
Membrane integration assessment:
Challenge: Confirming proper membrane insertion of the recombinant protein
Solution: Use fluorescent fusion proteins combined with confocal microscopy or membrane fractionation followed by Western blotting
Pore formation activity:
Challenge: Directly measuring the pore-forming ability of cidA
Solution: Liposome leakage assays with encapsulated fluorescent dyes or electrophysiological measurements using planar lipid bilayers
Cell lysis regulation:
Challenge: Distinguishing cidA's direct effects from downstream consequences
Solution: Complementation studies in cidA mutants with controlled expression of wild-type or modified recombinant cidA
Interaction with murein hydrolases:
Challenge: Determining specific protein-protein interactions
Solution: Co-immunoprecipitation, bacterial two-hybrid assays, or surface plasmon resonance with purified components
When designing these assays, researchers should include appropriate controls such as heat-inactivated protein, mutant versions of cidA with altered key residues, and comparative analyses with homologous proteins from other bacterial species.
Research on S. aureus has demonstrated that cidA-controlled cell lysis plays a significant role in biofilm development, with released genomic DNA serving as an important structural component of the biofilm matrix . This finding suggests several research directions for B. subtilis cidA:
Comparative biofilm analysis:
Generate B. subtilis cidA mutants and assess biofilm formation quantitatively and qualitatively
Compare extracellular DNA (eDNA) content in wild-type versus mutant biofilms
Evaluate the effect of DNase treatment on biofilm stability
Potential anti-biofilm applications:
Testing cidA inhibitors as anti-biofilm agents
Development of strategies targeting cidA-mediated eDNA release
Combination approaches targeting both protein function and biofilm matrix components
In S. aureus studies, cidA mutant biofilms exhibited a rougher appearance compared with the parental strain and were less adherent . Additionally, quantitative real-time PCR experiments demonstrated the presence of 5-fold less genomic DNA in the cidA mutant biofilm relative to the wild type . Treatment of wild-type biofilms with DNase I caused extensive cell detachment, whereas similar treatment of the cidA mutant biofilm had only a modest effect . These findings suggest that targeting cidA function could be a viable approach to controlling biofilm formation in multiple bacterial species.
As a protein involved in bacterial cell lysis and death pathways, cidA may significantly impact antimicrobial susceptibility and resistance development. Researchers can investigate this relationship through:
Susceptibility testing protocols:
Compare minimum inhibitory concentrations (MICs) of various antibiotics against wild-type and cidA mutant strains
Evaluate the rate of killing by time-kill assays to assess differences in bactericidal activity
Examine post-antibiotic effect duration in the presence or absence of functional cidA
Stress response analysis:
Monitor cidA expression levels in response to sub-lethal antibiotic exposure using qRT-PCR or reporter gene fusions
Assess whether pre-activation or inhibition of cidA pathways alters subsequent antibiotic susceptibility
Investigate potential cross-talk between cidA regulation and known antibiotic resistance mechanisms
Persister cell formation:
Determine if cidA affects the formation of antibiotic-tolerant persister cells
Evaluate whether cidA mutants show altered persister frequencies under various stress conditions
Investigate the molecular mechanisms connecting cidA function to persistence phenotypes
This research direction is particularly relevant given the increasing concern about antimicrobial resistance and the need for novel therapeutic targets. Establishing connections between cell death pathways and antibiotic efficacy could reveal new combination strategies to enhance existing antimicrobials.
When designing experiments to study cidA function across different bacterial species, researchers should implement the following controls and experimental design considerations:
Genetic controls:
Include both positive (wild-type) and negative (complete gene deletion) controls
Use complementation strains where the mutant has the wild-type gene reintroduced to verify phenotype specificity
Consider using point mutations in key functional domains as additional controls
Physiological variables to control:
Growth phase: cidA effects may be growth-phase dependent, particularly in stationary phase when lysis typically occurs
Media composition: nutrient availability may affect cidA expression and function
Environmental stress: temperature, pH, osmolarity, and oxygen availability
Cross-species considerations:
Account for different genetic backgrounds when comparing cidA function between species
Consider synteny and genetic context of cidA in different organisms
Validate antibodies or detection methods across species due to potential sequence variations
Quantitative measurements:
Use multiple, complementary methods to assess cell lysis (e.g., optical density, viable counts, enzyme release assays)
Implement appropriate statistical analyses for biological replicates
Consider population heterogeneity by including single-cell analyses when possible
The study of cidA and related bacterial cell death mechanisms presents several promising research avenues:
Structural biology approaches:
Determination of cidA's three-dimensional structure to understand its membrane integration and pore formation mechanism
Structure-guided design of specific inhibitors or modulators of cidA function
Systems biology integration:
Comprehensive mapping of the cidA regulon across different bacterial species
Integration of transcriptomic, proteomic, and metabolomic data to understand the broader impact of cidA-mediated processes
Host-pathogen interaction studies:
Investigation of how cidA-mediated eDNA release affects host immune recognition
Exploration of cidA's potential role in horizontal gene transfer during infection
Therapeutic applications:
Development of anti-biofilm strategies targeting cidA-dependent processes
Evaluation of cidA modulators as antibiotic adjuvants to enhance treatment efficacy